Amedeo Smart

Free Medical Literature Service


 

Amedeo

Alzheimer's Disease

  Free Subscription

Articles published in
Nat Med
    August 2021
  1. JABBARI E, Duff KE
    Tau-targeting antibody therapies: too late, wrong epitope or wrong target?
    Nat Med. 2021;27:1341-1342.
    >> Share

    July 2021
  2. RABINOVICI GD
    Dominantly inherited Alzheimer's disease: a compass for drug development.
    Nat Med. 2021 Jul 5. pii: 10.1038/s41591-021-01434.
    >> Share

    June 2021
  3. SALLOWAY S, Farlow M, McDade E, Clifford DB, et al
    A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease.
    Nat Med. 2021 Jun 21. pii: 10.1038/s41591-021-01369.
    >> Share

  4. HANSSON O
    Biomarkers for neurodegenerative diseases.
    Nat Med. 2021;27:954-963.
    >> Share

    May 2021
  5. PALMQVIST S, Tideman P, Cullen N, Zetterberg H, et al
    Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures.
    Nat Med. 2021 May 24. pii: 10.1038/s41591-021-01348.
    >> Share

    April 2021
  6. VOGEL JW, Young AL, Oxtoby NP, Smith R, et al
    Four distinct trajectories of tau deposition identified in Alzheimer's disease.
    Nat Med. 2021 Apr 29. pii: 10.1038/s41591-021-01309.
    >> Share

    January 2021
  7. DUJARDIN S, Commins C, Lathuiliere A, Beerepoot P, et al
    Author Correction: Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease.
    Nat Med. 2021 Jan 29. pii: 10.1038/s41591-021-01251.
    >> Share

    November 2020
  8. ARNOLD C
    Post-hoc analysis could give new life to the Alzheimer's drug aducanumab.
    Nat Med. 2020 Nov 2. pii: 10.1038/d41591-020-00031.
    >> Share

    June 2020
  9. DUJARDIN S, Commins C, Lathuiliere A, Beerepoot P, et al
    Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease.
    Nat Med. 2020 Jun 22. pii: 10.1038/s41591-020-0938.
    >> Share

    May 2020
  10. ZHOU Y, Song WM, Andhey PS, Swain A, et al
    Author Correction: Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease.
    Nat Med. 2020 May 14. pii: 10.1038/s41591-020-0922.
    >> Share

    April 2020
  11. JOHNSON ECB, Dammer EB, Duong DM, Ping L, et al
    Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation.
    Nat Med. 2020 Apr 13. pii: 10.1038/s41591-020-0815.
    >> Share

    March 2020
  12. BATEMAN RJ, Barthelemy NR, Horie K
    Another step forward in blood-based diagnostics for Alzheimer's disease.
    Nat Med. 2020 Mar 4. pii: 10.1038/s41591-020-0797.
    >> Share

  13. THIJSSEN EH, La Joie R, Wolf A, Strom A, et al
    Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration.
    Nat Med. 2020 Mar 2. pii: 10.1038/s41591-020-0762.
    >> Share

  14. JANELIDZE S, Mattsson N, Palmqvist S, Smith R, et al
    Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia.
    Nat Med. 2020 Mar 2. pii: 10.1038/s41591-020-0755.
    >> Share

  15. BARTHELEMY NR, Li Y, Joseph-Mathurin N, Gordon BA, et al
    A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease.
    Nat Med. 2020;26:398-407.
    >> Share

    January 2020
  16. ZHOU Y, Song WM, Andhey PS, Swain A, et al
    Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease.
    Nat Med. 2020;26:131-142.
    >> Share

    November 2019
  17. ARBOLEDA-VELASQUEZ JF, Lopera F, O'Hare M, Delgado-Tirado S, et al
    Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report.
    Nat Med. 2019 Nov 4. pii: 10.1038/s41591-019-0611.
    >> Share

  18. ZALOCUSKY KA, Nelson MR, Huang Y
    An Alzheimer's-disease-protective APOE mutation.
    Nat Med. 2019 Nov 4. pii: 10.1038/s41591-019-0634.
    >> Share

    May 2019
  19. STOWER H
    Improving cognition.
    Nat Med. 2019;25:710.
    >> Share

    April 2019
  20. STEINER E, Tata M, Frisen J
    A fresh look at adult neurogenesis.
    Nat Med. 2019;25:542-543.
    >> Share

    March 2019
  21. MORENO-JIMENEZ EP, Flor-Garcia M, Terreros-Roncal J, Rabano A, et al
    Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer's disease.
    Nat Med. 2019 Mar 25. pii: 10.1038/s41591-019-0375.
    >> Share

  22. STOWER H
    Linking Alzheimer's disease and frailty.
    Nat Med. 2019 Mar 6. pii: 10.1038/s41591-019-0399.
    >> Share

    February 2019
  23. ZETTERBERG H, Schott JM
    Biomarkers for Alzheimer's disease beyond amyloid and tau.
    Nat Med. 2019;25:201-203.
    >> Share

  24. STOWER H
    Transmission of Abeta seeds.
    Nat Med. 2019;25:197.
    >> Share

    January 2019
  25. PREISCHE O, Schultz SA, Apel A, Kuhle J, et al
    Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease.
    Nat Med. 2019 Jan 21. pii: 10.1038/s41591-018-0304.
    >> Share

  26. LOURENCO MV, Frozza RL, de Freitas GB, Zhang H, et al
    Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer's models.
    Nat Med. 2019;25:165-175.
    >> Share

  27. CHEN X, Gan L
    An exercise-induced messenger boosts memory in Alzheimer's disease.
    Nat Med. 2019;25:20-21.
    >> Share

    December 2018
  28. STOWER H
    Meningeal lymphatics in aging and Alzheimer's disease.
    Nat Med. 2018;24:1781.
    >> Share

    July 2018
  29. STOWER H
    Searching for Alzheimer's disease therapies.
    Nat Med. 2018;24:894-897.
    >> Share

    May 2018
  30. SANCHEZ-MUT JV, Heyn H, Silva BA, Dixsaut L, et al
    PM20D1 is a quantitative trait locus associated with Alzheimer's disease.
    Nat Med. 2018 May 7. pii: 10.1038/s41591-018-0013.
    >> Share

    April 2018
  31. CHAKRADHAR S
    A tale of two diseases: Aging HIV patients inspire a closer look at Alzheimer's disease.
    Nat Med. 2018;24:376-377.
    >> Share

    December 2017
  32. HE Z, Guo JL, McBride JD, Narasimhan S, et al
    Amyloid-beta plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation.
    Nat Med. 2017 Dec 4. pii: nm.4443. doi: 10.1038/nm.4443.
    >> Share

    September 2017
  33. SALTER MW, Stevens B
    Microglia emerge as central players in brain disease.
    Nat Med. 2017;23:1018-1027.
    >> Share

    May 2017
  34. LAM AD, Deck G, Goldman A, Eskandar EN, et al
    Silent hippocampal seizures and spikes identified by foramen ovale electrodes in Alzheimer's disease.
    Nat Med. 2017 May 1. doi: 10.1038/nm.4330.
    >> Share

    February 2017
  35. WONG YC, Krainc D
    alpha-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies.
    Nat Med. 2017;23:1-13.
    >> Share

    October 2016
  36. KINCAID E
    Picture imperfect: Going beyond imaging amyloid in Alzheimer's disease.
    Nat Med. 2016;22:1067-1068.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016